PRC2 inhibitors overcome glucocorticoid resistance driven by NSD2 mutation in pediatric acute lymphoblastic leukemia - Li, J; Hlavka-Zhang, J; Shrimp, J H; Piper, C; Dupere-Richer, D; Roth, J S; Jing, D; Casellas Roman, H L; Troche, C; Swaroop, A; Kulis, M; Oyer, J A; Will, C M; Shen, M; Riva, A; Bennett, R L; Ferrando, A A; Hall, M D; Lock, R B; Licht, J D (Cancer Discov, 2022)